<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M863</article-id>
      <article-id pub-id-type="publisher-id">molbank-2015-M863</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>1-[3-(2-Methyl-4-phenylquinolin-3-yl)-5-phenyl-4,5-dihydro-1<italic>H</italic>-pyrazol-1-yl]-propane-1-one</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kedjadja</surname>
            <given-names>Allaoua</given-names>
          </name>
          <xref rid="af1-molbank-2015-M863" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2015-M863" ref-type="aff">2</xref>
          <xref rid="c1-molbank-2015-M863" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kolli</surname>
            <given-names>Elhadj</given-names>
          </name>
          <xref rid="af1-molbank-2015-M863" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bouraiou</surname>
            <given-names>Abdelmalek</given-names>
          </name>
          <xref rid="af3-molbank-2015-M863" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Merdes</surname>
            <given-names>Rachid</given-names>
          </name>
          <xref rid="af1-molbank-2015-M863" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Haider</surname>
            <given-names>Norbert</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2015-M863"><label>1</label>Laboratoire de Chimie Appliqu&#xE9;e, Facult&#xE9; des Math&#xE9;matiques et de l&#x2019;Informatique et des Sciences de la Mati&#xE8;re, Universit&#xE9; de Guelma, Guelma 24000, Algeria; E-Mails: <email>kollielhadj@gmail.com</email> (E.K.); <email>merdesra@yahoo.fr</email> (R.M.)</aff>
      <aff id="af2-molbank-2015-M863"><label>2</label>D&#xE9;partement de Tronc Commun, Facult&#xE9; des Science de la Nature et de la Vie, Universit&#xE9; Abderrahmane Mira, Bejaia 6000, Algeria</aff>
      <aff id="af3-molbank-2015-M863"><label>3</label>Unit&#xE9; de Recherche de Chimie de l&#x2019;Environnement et Mol&#xE9;culaire Structurale, Universit&#xE9; des Fr&#xE8;res Mentouri, Route de Ain El Bey, Constantine 25000, Algeria; E-Mail: <email>bouraiou.abdelmalek@yahoo.fr</email></aff>
      <author-notes>
        <corresp id="c1-molbank-2015-M863"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>kedjadjaalla@yahoo.fr</email> or <email>allaoua.kedjadja@univ-bejaia.dz</email>; Tel.: +213-07-73012507; Fax: +213-031818816.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>06</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>06</month>
        <year>2015</year>
      </pub-date>
      <volume>2015</volume>
      <issue>2</issue>
      <elocation-id>M863</elocation-id>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>03</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>09</day>
          <month>06</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A novel compound, 1-[3-(2-methyl-4-phenylquinolin-3-yl)-5-phenyl-4,5-dihydro-1<italic>H</italic>-pyrazol-1-yl]-propane-1-one (<bold>3</bold>) has been synthesized by cyclocondensation of (<italic>E</italic>)-1-(2-methyl-4-phenylquinolin-3-yl)-3-phenylprop-2-en-1-one (<bold>2</bold>) and hydrazine hydrate in propionic acid. The structure of this compound was established by elemental analysis, IR, <sup>1</sup>H-NMR, <sup>13</sup>C-NMR and MS data.</p>
      </abstract>
      <kwd-group>
        <kwd>quinoline</kwd>
        <kwd>cyclocondensation</kwd>
        <kwd>pyrazoline</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>Quinoline and its derivatives have been widely found in natural products and synthetic pharmaceuticals, which are associated with a broad spectrum of biological activities [<xref ref-type="bibr" rid="B1-molbank-2015-M863">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2015-M863">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2015-M863">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2015-M863">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2015-M863">5</xref>]. On the other hand, pyrazolines are important nitrogen-containing five-membered heterocyclic compounds, and their derivatives have been found to possess a broad spectrum of biological activities, such as antimalarial, antitrypanosomal, antitumor, and antidepressant activities [<xref ref-type="bibr" rid="B6-molbank-2015-M863">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2015-M863">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2015-M863">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2015-M863">9</xref>,<xref ref-type="bibr" rid="B10-molbank-2015-M863">10</xref>,<xref ref-type="bibr" rid="B11-molbank-2015-M863">11</xref>]. The coupling of this chemical entity with a quinoline unit might be considered to have some biological activities. In this context, we report in this paper the synthesis of a novel 3-(quinolin-3-yl)-2-pyrazoline by cyclocondensation of the known (<italic>E</italic>)-1-(2-methyl-4-phenylquinolin-3-yl)-3-phenylprop-2-en-1-one (<bold>2</bold>) with hydrazine hydrate.</p>
	  <fig id="molbank-2015-M863-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2015-M863-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>The synthesis of 1-[3-(2-methyl-4-phenylquinolin-3-yl)-5-phenyl-4,5-dihydro-1<italic>H</italic>-pyrazol-1-yl]-propane-1-one.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M863-sch001.tif"/>
      </fig>
    <sec>
      <title>Experimental Section</title>
	  <sec>
      <title>Synthesis of 1-[3-(2-Methyl-4-phenylquinolin-3-yl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]-propane-1-one <italic>(<bold>3</bold>)</italic></title>
      <p>A mixture of 3-acetyl-2-methyl-4-phenylquinoline (2.6 g, 0.01 mol) (<bold>1</bold>), benzaldehyde (1.06 g, 0.01 mol) and 0.6 g of NaOH (0.015 mol) in 40 mL of ethanol was stirred at room temperature for 12 h. The resulting mixture was concentrated, then poured onto ice and neutralized with acetic acid. The resultant solid was filtered, dried and purified by column chromatography on silica gel using a mixture of ethyl acetate and petroleum ether (1:1). Recrystallization from the mixture of petroleum ether/acetone (8:4) gives the intermediate compound (<bold>2</bold>), m.p.: 149&#x2013;150 &#xB0;C, yield: 82%. Compound 2 is known in literature [<xref ref-type="bibr" rid="B12-molbank-2015-M863">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2015-M863">13</xref>] and its structure has been confirmed by spectroscopic methods. Next, the title compound (<bold>3</bold>) was prepared by heating (<italic>E</italic>)-1-(2-methyl-4-phenylquinolin-3-yl)-3-phenylprop-2-en-1-one <bold>2</bold>(0.5 g, 0.0014 mol) and hydrazine hydrate (0.070 g, 0.0014 mol) in propionic acid (20 mL) at 115&#x2013;120 &#xB0;C for 4 h. After completion, the solution was concentrated, cooled, and then poured onto ice. The resulting solid was filtered, washed with water, dried, and then recrystallized from the ethanol/petroleum ether mixture (2:1). The starting materials were generally used as received (Acros, Aldrich) without any further purification. Melting points were determined on an Electrothermal Digital Melting Point Apparatus (IA 9200) and are uncorrected. <sup>1</sup>H-NMR and <sup>13</sup>C-NMR spectra were recorded on VARIAN Mercury 300 spectrometers, CSIC, Spain.</p>
      <p>White crystals; Yield: 92%; m.p. = 210 &#xB0;C.</p>
      <p>HRMS (ESI): [M + H]<sup>+</sup> calculated for C<sub>28</sub>H<sub>26</sub>N<sub>3</sub>O = 420.2076; found 420.2092. </p>
      <p>IR (KBr) <italic>v</italic><sub>max</sub> cm<sup>&#x2212;1</sup>: 1666.8 (C=O ketone), 1618.0 (C=N pyrazoline)</p>
      <p><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>) &#x3B4;: 8.13 (d, <italic>J</italic> = 8.3 Hz, 1H, H-8), 7.75 (td, <italic>J</italic> = 8.3 Hz, <italic>J</italic> = 1.8 Hz, 1H, H-7), 7.53&#x2013;7.25 (m, 10H, H-Ar), 6.90-6.84 (m, 2H, H-Ar), 5.35 (dd, <italic>J</italic> = 11.9 Hz, <italic>J</italic> = 5.1 Hz, 1H, H-5 pyrazoline), 3.44 (dd, <italic>J</italic> = 18.6 Hz, <italic>J</italic> = 12.0 Hz, 1H, H-4 pyrazoline), 2.82 (s, 3H, CH<sub>3</sub>), 2.73 (q, <italic>J</italic> = 7.6 Hz, 2H, CH<sub>2</sub>), 2.53 (dd, <italic>J</italic> = 18.5 Hz, <italic>J</italic> = 5.1 Hz, 1H, H-4&#x2B9; pyrazoline), 1.18 (t, <italic>J</italic> = 7.5 Hz, 3H, CH<sub>3</sub>).</p>
      <p><sup>13</sup>C-NMR (75.4 MHz, CDCl<sub>3</sub>) &#x3B4;: 172.50 (CO), 156.57 (C, C3 pyrazoline), 153.82, 148.28, 147.55, 141.62, 135.77, 130.40, 130.09, 123.84, 128.87, 128.70, 128.57, 127.54, 126.58, 126.42, 125.80, 125.62, 124.74 (C, CH phenyl and quinoline, 21C), 59.69 (CH, C5 pyrazoline), 46.51 (CH<sub>2</sub>, C4 pyrazoline), 27.83 (CH<sub>2</sub>), 24.81 (CH<sub>3</sub>), 9.2 (CH<sub>3</sub>).</p>
      <p>Anal. calcd. For C<sub>28</sub>H<sub>25</sub>N<sub>3</sub>O: C, 80.16; H, 6.01; N, 10.02; Found C, 79.92; H, 6.19; N, 9.96.</p>
    </sec>
	</sec>
  </body>
  <back>
    <app-group>
    <app id="app1-molbank-2015-M863">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2015-M863-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M863-s001-mod.mol">
		<label>Supplementary File 1</label>
		</supplementary-material>
        <supplementary-material id="molbank-2015-M863-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M863-s001.mol">
		<label>Supplementary File 2</label>
		</supplementary-material>
        </app>
	</app-group>
    <notes>
      <title>Author Contributions</title>
      <p>Allaoua Kedjadja and Rachid Merdes have contributed to the experimental part of this work. Experimental characterization was made by Elhadj Kolli. Abdelmalek Bouraiou contributed to the preparation of the manuscript. All authors read and approve the final manuscript.</p>
    </notes>
    <notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2015-M863">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morimoto</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Shirahama</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Total Synthesis of (&#xB1;)-Virantmycin and Determination of Its Stereochemistry</article-title>
          <source>Synlett</source>
          <year>1991</year>
          <volume>1991</volume>
          <fpage>202</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="doi">10.1055/s-1991-20680</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2015-M863">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Markees</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Dewey</surname>
              <given-names>V.C.</given-names>
            </name>
            <name>
              <surname>Kidder</surname>
              <given-names>G.W.</given-names>
            </name>
          </person-group>
          <article-title>Antiprotozoal 4-aryloxy-2-aminoquinolines and related compounds</article-title>
          <source>J. Med. Chem.</source>
          <year>1970</year>
          <volume>13</volume>
          <fpage>324</fpage>
          <lpage>326</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00296a048</pub-id>
          <pub-id pub-id-type="pmid">5418519</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2015-M863">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Campbell</surname>
              <given-names>F.S.</given-names>
            </name>
            <name>
              <surname>Hardstone</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>2,4-Diamino-6,7-dimethoxyquinoline derivatives as .alpha.1-adrenoceptor antagonists and antihypertensive agents</article-title>
          <source>J. Med. Chem.</source>
          <year>1988</year>
          <volume>31</volume>
          <fpage>1031</fpage>
          <lpage>1035</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00400a025</pub-id>
          <pub-id pub-id-type="pmid">2896245</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2015-M863">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maguire</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Sheets</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Zilberstein</surname>
              <given-names>A.A.</given-names>
            </name>
          </person-group>
          <article-title>New Series of PDGF Receptor Tyrosine Kinase Inhibitors: 3-Substituted Quinoline Derivatives</article-title>
          <source>J. Med. Chem.</source>
          <year>1994</year>
          <volume>37</volume>
          <fpage>2129</fpage>
          <lpage>2137</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00040a003</pub-id>
          <pub-id pub-id-type="pmid">8035419</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2015-M863">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Y.L.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Sheu</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Tzeng</surname>
              <given-names>C.C.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Antibacterial Evaluation of Certain Quinolone Derivatives</article-title>
          <source>J. Med. Chem.</source>
          <year>2001</year>
          <volume>44</volume>
          <fpage>2374</fpage>
          <lpage>2377</lpage>
          <pub-id pub-id-type="doi">10.1021/jm0100335</pub-id>
          <pub-id pub-id-type="pmid">11428933</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2015-M863">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Ram&#xED;rez</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Becerra</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Echeverry</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Abonia</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Robledo</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Dar&#xED;o V&#xE9;lez</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Upegui</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Mu&#x148;oz</surname>
              <given-names>J.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An efficient synthesis of new caffeine-based chalcones, pyrazolines and pyrazolo[3,4-<italic>b</italic>][1,4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agents</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2015</year>
          <volume>93</volume>
          <fpage>401</fpage>
          <lpage>413</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2015.02.040</pub-id>
          <pub-id pub-id-type="pmid">25725376</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2015-M863">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Montoya</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Becerra</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Abonia</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Robledo</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Dar&#xED;o V&#xE9;lez</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Upegui</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Mu&#x148;oz</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Nogueras</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl)amino]chalcones and hydrazine as potential antitumor and antimalarial agents</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2013</year>
          <volume>67</volume>
          <fpage>252</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2013.06.049</pub-id>
          <pub-id pub-id-type="pmid">23871905</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2015-M863">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Tigreros</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Orozco</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Abonia</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Nogueras</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Cobo</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1<italic>H</italic>-pyrazol-5-yl)-1-phenyl-1<italic>H</italic>-pyrazole derivatives as potential antitumor agents</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2010</year>
          <volume>18</volume>
          <fpage>4965</fpage>
          <lpage>4974</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2010.06.013</pub-id>
          <pub-id pub-id-type="pmid">20594863</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2015-M863">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sarveswari</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vijayakumar</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>An Efficient Microwave Assisted Eco-friendly Synthesis of 6-Chloro-3-(3-arylacryloyl)-2-methyl-4-phenylquinolines and their Conversion to 6-Chloro-3-(1-phenyl-5-aryl-4,5-dihydro-1<italic>H</italic>-pyrazol-3-yl)-2-methyl-4-phenylquinolines</article-title>
          <source>J. Chin. Chem. Soc.</source>
          <year>2012</year>
          <volume>59</volume>
          <fpage>66</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1002/jccs.201100162</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2015-M863">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prasad</surname>
              <given-names>Y.R.</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Prasoona</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Murali</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>P.R.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2&#x2033;-hydroxynaphthalen-1&#x2033;-yl)-1,5-diphenyl-2-pyrazolines</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>5030</fpage>
          <lpage>5034</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2005.08.040</pub-id>
          <pub-id pub-id-type="pmid">16168645</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2015-M863">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Negi</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Pant</surname>
              <given-names>G.J.N.</given-names>
            </name>
            <name>
              <surname>Rawat</surname>
              <given-names>M.S.M.</given-names>
            </name>
            <name>
              <surname>Budakoti</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Characterization of a Novel 2-Pyrazoline</article-title>
          <source>Molbank</source>
          <year>2009</year>
          <volume>2009</volume>
          <fpage>M614</fpage>
          <pub-id pub-id-type="doi">10.3390/M614</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2015-M863">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loh</surname>
              <given-names>W.-S.</given-names>
            </name>
            <name>
              <surname>Fun</surname>
              <given-names>H.-K.</given-names>
            </name>
            <name>
              <surname>Prasath</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sarveswari</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vijayakumar</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title><italic>(E</italic>)-1-(2-Methyl-4-phenylquinolin-3-yl)-3-phenylprop-2-en-1-one</article-title>
          <source>Acta Crystallogr.</source>
          <year>2011</year>
          <volume>E67</volume>
          <fpage>o764</fpage>
          <lpage>o765</lpage>
          <pub-id pub-id-type="doi">10.1107/S1600536811007057</pub-id>
          <pub-id pub-id-type="pmid">21754059</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2015-M863">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kotra</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Ganapaty</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Adapa</surname>
              <given-names>S.R.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of new series of quinolinyl chalcones as anticancer and anti-inflammatory agents</article-title>
          <source>Indian J. Chem. Sec. B</source>
          <year>2010</year>
          <volume>49</volume>
          <fpage>1109</fpage>
          <lpage>1116</lpage>
        </citation>
      </ref>
    </ref-list>
    </back>
</article>
